Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robot therapist: can AI ease emotional pain after cancer surgery?

NCT ID NCT07365761

Symptom relief Sponsor: National Taiwan University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is developing and testing a friendly AI robot called E-MOTE to provide emotional support to women who have just had surgery for gynecologic cancer. The robot will assess their distress and offer personalized psychological help. Researchers will measure whether the robot reduces emotional distress, improves quality of life, and is easy to use. About 130 patients and their nurses will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 130 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Stage 1 (For patients and nurse) \*\*\*Patients\*\*\* Inclusion Criteria: * Aged 18 years or older. * Diagnosed with gynecologic cancer and undergoing surgery. * Willing to receive E-MOTE robot and wear a smart wearable device. * Willing to complete pre-test and post-test questionnaires. Exclusion Criteria: * Unable to communicate clearly. * Unwilling or unable to participate in the study in its entirety. \*\*\*Nurse\*\*\* Inclusion Criteria: * Aged 18 years or older. * As a clinical nurse and has cared for patients who received the E-MOTE robot Exclusion Criteria: \- Unwilling to participate in the qualitative interview. Stage 2 (only for patients) \*\*\*Intervention group\*\*\* Inclusion Criteria: * Aged 18 years or older. * Diagnosed with gynecologic cancer and scheduled to undergo surgery. * Willing to receiveE-MOTE robot and to wear a smart wearable device. * Willing to complete pre-test and post-test questionnaires. Exclusion Criteria: * Unable to communicate clearly. * Unwilling or unable to participate in the study in its entirety. \*\*\*Control group\*\*\* Inclusion Criteria: * Aged 18 years or older. * Diagnosed with gynecologic cancer and scheduled to undergo surgery. * Willing to complete pre-test and post-test questionnaires. Exclusion Criteria: * Unable to communicate clearly. * Unwilling or unable to participate in the study in its entirety.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Emotional assessment are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

female reproductive organ cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Emotional assessment Gynecological cancers Nursing

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • National Taiwan University

    RECRUITING

    Taipei, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.